Stock Analysis on Net
Stock Analysis on Net
Microsoft Excel LibreOffice Calc

Abbott Laboratories (NYSE:ABT)

Common-Size Income Statement

Beginner level

Abbott Laboratories, common-size consolidated income statement

Microsoft Excel LibreOffice Calc
12 months ended: Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Net sales 100.00 100.00 100.00 100.00 100.00
Cost of products sold, excluding amortization of intangible assets -41.47 -41.55 -45.04 -43.27 -42.87
Amortization of intangible assets -6.07 -7.12 -7.21 -2.64 -2.95
Gross profit 52.46% 51.32% 47.75% 54.09% 54.19%
Research and development -7.65 -7.52 -8.16 -6.82 -6.89
Selling, general and administrative -30.61 -31.87 -33.29 -32.00 -33.25
Operating earnings 14.21% 11.94% 6.30% 15.27% 14.05%
Interest expense -2.10 -2.70 -3.30 -2.07 -0.80
Interest income 0.29 0.34 0.45 0.47 0.51
Net foreign exchange gain (loss) -0.02 -0.09 0.12 -2.37 0.46
Debt extinguishment costs -0.20 -0.55 0.00 0.00 0.00
Other income (expense), net 0.60 0.45 4.57 -4.53 1.38
Earnings from continuing operations before taxes 12.78% 9.40% 8.15% 6.78% 15.60%
Taxes on earnings from continuing operations -1.22 -1.76 -6.86 -1.68 -2.83
Earnings from continuing operations 11.56% 7.63% 1.29% 5.10% 12.77%
Earnings from discontinued operations, net of taxes 0.00 0.11 0.45 1.54 0.32
Gain on sale of discontinued operations, net of taxes 0.00 0.00 0.00 0.08 8.59
Net earnings from discontinued operations, net of taxes 0.00% 0.11% 0.45% 1.62% 8.90%
Net earnings 11.56% 7.74% 1.74% 6.71% 21.68%

Based on: 10-K (filing date: 2020-02-21), 10-K (filing date: 2019-02-22), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19).

Income statement item Description The company
Operating earnings The net result for the period of deducting operating expenses from operating revenues. Abbott Laboratories’s operating earnings as a percentage of net sales increased from 2017 to 2018 and from 2018 to 2019.
Earnings from continuing operations before taxes Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Abbott Laboratories’s earnings from continuing operations before taxes as a percentage of net sales increased from 2017 to 2018 and from 2018 to 2019.
Net earnings The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Abbott Laboratories’s net earnings as a percentage of net sales increased from 2017 to 2018 and from 2018 to 2019.